한글목차

일본뇌염 백신 시장은 2023-2028년 7,569만 달러 규모에 달할 것으로 예상되며, 예측 기간 동안 6.29%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서에서는 일본 뇌염 백신 시장의 전체 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 국가 예방접종 계획에 일본뇌염 백신의 포함, 일본뇌염 백신 개발을 위한 전략적 제휴, 일본뇌염에 대한 인식 제고 캠페인의 증가 등이 시장을 주도하고 있습니다.

이 보고서는 향후 수년간 일본뇌염 백신 시장 성장을 견인할 주요 요인 중 하나로 새로운 일본뇌염 백신 기술 개발을 꼽았습니다. 또한, BRICS의 활발한 연구 투자와 아시아 인바운드 여행객의 증가도 시장 수요에 큰 영향을 미칠 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계

제3장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 일본뇌염 백신 세계 시장 2018-2022
• 유형별 부문 분석 2018-2022
• 유통 채널별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 불활화 백신 : 시장 규모와 예측 2023-2028
• 재조합 백신 : 시장 규모와 예측 2023-2028
• 약독화 생백신 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유형별

제7장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 병원 약국 : 시장 규모와 예측 2023-2028
• 소매 약국 : 시장 규모와 예측 2023-2028
• 온라인 약국 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유통 채널별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 아시아 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 북미 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 인도 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 한국 : 시장 규모와 예측 2023-2028
• 호주 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 상황

• 개요
• 벤더 상황
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Adimmune Corp.
• Bharat Biotech Ltd.
• Biological E. Ltd.
• Medigen Inc.
• Meiji Holdings Co. Ltd.
• Panacea Biotec Ltd.
• Sanofi SA
• Shandong Hengye Biotechnology Co. Ltd.

제13장 부록

영문목차

The japanese encephalitis vaccines market is forecasted to grow by USD 75.69 mn during 2023-2028, accelerating at a CAGR of 6.29% during the forecast period. The report on the japanese encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by inclusion of japanese encephalitis vaccines in national immunization plan, strategic alliances for japanese encephalitis vaccine development, and growing number of awareness campaigns regarding japanese encephalitis.

Technavio's japanese encephalitis vaccines market is segmented as below:

By Type

• Inactivated vaccines
• Recombinant vaccines
• Live attenuated vaccines

By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Geographical Landscape

• Asia
• Europe
• North America
• Rest of World (ROW)

This study identifies the developments of novel japanese encephalitis vaccine technology as one of the prime reasons driving the japanese encephalitis vaccines market growth during the next few years. Also, strong investments from brics in research and growing inbound travel to asia will lead to sizable demand in the market.

The report on the japanese encephalitis vaccines market covers the following areas:

• Japanese encephalitis vaccines market sizing
• Japanese encephalitis vaccines market forecast
• Japanese encephalitis vaccines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading japanese encephalitis vaccines market vendors that include Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., Medigen Inc., Meiji Holdings Co. Ltd., Panacea Biotec Ltd., Sanofi SA, and Shandong Hengye Biotechnology Co. Ltd.. Also, the japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Japanese encephalitis vaccines market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global japanese encephalitis vaccines market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Inactivated vaccines - Market size and forecast 2023-2028
• Exhibit 34: Chart on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
• 6.4 Recombinant vaccines - Market size and forecast 2023-2028
• Exhibit 38: Chart on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
• 6.5 Live attenuated vaccines - Market size and forecast 2023-2028
• Exhibit 42: Chart on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ million)
• Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 50: Chart on Comparison by Distribution Channel
• Exhibit 51: Data Table on Comparison by Distribution Channel
• 7.3 Hospital pharmacy - Market size and forecast 2023-2028
• Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• 7.4 Retail pharmacy - Market size and forecast 2023-2028
• Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• 7.5 Online pharmacy - Market size and forecast 2023-2028
• Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 64: Market opportunity by Distribution Channel ($ million)
• Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 North America - Market size and forecast 2023-2028
• Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 China - Market size and forecast 2023-2028
• Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.8 India - Market size and forecast 2023-2028
• Exhibit 91: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 South Korea - Market size and forecast 2023-2028
• Exhibit 99: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on South Korea - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
• 9.11 Australia - Market size and forecast 2023-2028
• Exhibit 103: Chart on Australia - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on Australia - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Australia - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Adimmune Corp.
• Exhibit 115: Adimmune Corp. - Overview
• Exhibit 116: Adimmune Corp. - Product / Service
• Exhibit 117: Adimmune Corp. - Key offerings
• 12.4 Bharat Biotech Ltd.
• Exhibit 118: Bharat Biotech Ltd. - Overview
• Exhibit 119: Bharat Biotech Ltd. - Product / Service
• Exhibit 120: Bharat Biotech Ltd. - Key news
• Exhibit 121: Bharat Biotech Ltd. - Key offerings
• 12.5 Biological E. Ltd.
• Exhibit 122: Biological E. Ltd. - Overview
• Exhibit 123: Biological E. Ltd. - Product / Service
• Exhibit 124: Biological E. Ltd. - Key offerings
• 12.6 Medigen Inc.
• Exhibit 125: Medigen Inc. - Overview
• Exhibit 126: Medigen Inc. - Product / Service
• Exhibit 127: Medigen Inc. - Key offerings
• 12.7 Meiji Holdings Co. Ltd.
• Exhibit 128: Meiji Holdings Co. Ltd. - Overview
• Exhibit 129: Meiji Holdings Co. Ltd. - Business segments
• Exhibit 130: Meiji Holdings Co. Ltd. - Key news
• Exhibit 131: Meiji Holdings Co. Ltd. - Key offerings
• Exhibit 132: Meiji Holdings Co. Ltd. - Segment focus
• 12.8 Panacea Biotec Ltd.
• Exhibit 133: Panacea Biotec Ltd. - Overview
• Exhibit 134: Panacea Biotec Ltd. - Product / Service
• Exhibit 135: Panacea Biotec Ltd. - Key offerings
• 12.9 Sanofi SA
• Exhibit 136: Sanofi SA - Overview
• Exhibit 137: Sanofi SA - Business segments
• Exhibit 138: Sanofi SA - Key news
• Exhibit 139: Sanofi SA - Key offerings
• Exhibit 140: Sanofi SA - Segment focus
• 12.10 Shandong Hengye Biotechnology Co. Ltd.
• Exhibit 141: Shandong Hengye Biotechnology Co. Ltd. - Overview
• Exhibit 142: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
• Exhibit 143: Shandong Hengye Biotechnology Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 144: Inclusions checklist
• Exhibit 145: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 146: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 147: Research methodology
• Exhibit 148: Validation techniques employed for market sizing
• Exhibit 149: Information sources
• 13.5 List of abbreviations
• Exhibit 150: List of abbreviations